Statements (41)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
amphetamine
alkaloid |
| gptkbp:ATCCode |
C01CA13
|
| gptkbp:CASNumber |
94-07-5
|
| gptkbp:chemicalFormula |
C9H13NO2
|
| gptkbp:drugClass |
vasoconstrictor
appetite suppressant adrenergic agonist |
| gptkbp:firstIsolatedFrom |
gptkb:Citrus_aurantium
|
| gptkbp:foundIn |
gptkb:bitter_orange
|
| gptkbp:has_hazard |
may cause arrhythmia
may increase blood pressure may interact with MAO inhibitors |
| https://www.w3.org/2000/01/rdf-schema#label |
Synephrine
|
| gptkbp:isomerOf |
meta-synephrine
ortho-synephrine para-synephrine |
| gptkbp:IUPACName |
4-[1-hydroxy-2-(methylamino)ethyl]phenol
|
| gptkbp:legalStatus |
banned by NCAA
banned by World Anti-Doping Agency |
| gptkbp:meltingPoint |
187–188 °C
|
| gptkbp:metabolism |
liver
|
| gptkbp:molecularWeight |
167.21 g/mol
|
| gptkbp:PubChem_CID |
5988
CHEBI:29085 CHEMBL1201242 DB06707 |
| gptkbp:relatedTo |
gptkb:ephedrine
gptkb:phenylephrine |
| gptkbp:routeOfAdministration |
oral
topical |
| gptkbp:sideEffect |
anxiety
headache hypertension tachycardia |
| gptkbp:solubility |
soluble in water
|
| gptkbp:UNII |
4986QIC43M
|
| gptkbp:usedFor |
stimulant
weight loss supplement |
| gptkbp:bfsParent |
gptkb:Bitter_Orange
|
| gptkbp:bfsLayer |
7
|